Incidence of leukopenia and cytomegalovirus disease in kidney transplants treated with mycophenolate mofetil combined with low cyclosporine and steroid doses

Clinical Transplantation

Volumn 12, Issue 3, 1998, Pages 198-205

  Moreso, Francesc ^a   Serón, Daniel ^a   Morales, José M ^b   Cruzado, Josep M ^a   Gil Vernet, Salvador ^a   Pérez, José L ^a   Fulladosa, Xavier ^a   Andrés, Amado ^b   Grinyó, Josep M ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Cytomegalovirus disease; Leukopenia; Mycophenolate mofetil; Renal transplant

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANALYSIS OF VARIANCE; ANTI-INFLAMMATORY AGENTS; CLINICAL TRIALS; CYCLOSPORINE; CYTOMEGALOVIRUS INFECTIONS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY TRANSPLANTATION; LEUKOPENIA; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PREDNISONE; SURVIVAL ANALYSIS;

EID: 0031809116     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. ALLISON AC, EUGUI EM. Mycophenolate mofetil, a rationally designed immunosuppressive drug. Clin Transplant 1993: 7: 96.
2. European Mycophenolate Mofetil Cooperative Study Group. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet 1995: 345: 1321.
3. SOLLINGER HW. for the US Renal Transplant Mycophenolate Mofetil Study Group, Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 1995: 60: 225.
4. The Tncontinental Mycophenolate Mofetil Renal Transplantation Study Group. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 1996: 61: 1029.
5. LJUNGMAN P, GRIFFITHS P. Definitions of CMV infections and disease. In: MICHELSON S, PLOTKIN SA, eds. Multidisciplinary approach to understanding of CMV disease. Paris: Elsevier, 1993: 233.
6. STAGNO S, BRITT WJ, PASS RF. Cytomegalovirus. In: SCHMIDT NF, EMMONS RW, eds. Diagnostic procedures for viral, rickettsial and chlamydial infections. Washington DC: American Public Health Association, 1989: 321.
7. GLEAVES CA, SMITH TF, SHUSTER EA, PEARSON GR. Comparison of standard tube and shell vial cell culture techniques for the detection of cytomegalovirus in clinical specimens. J Clin Microbiol 1985: 21: 217.
8. NIUBÓ J, PÉREZ JL, CARVAJAL A, ARDANUY C, MARTiN R. Effect of delayed processing of blood samples on the performance of cytomegalovirus antigenemia assay. J Clin Microbiol 1994: 32: 1119.
9. PÉREZ JL, DE OÑA M, NIUBÓ J, et al. Comparison of several fixation methods for cytomegalovirus antigenemia assay. J Clin Microbiol 1995: 33: 1646.
10. Canadian Multicenter Transplant Study Group. A randomized clinical trial of cyclosporine in cadaveric renal transplantation. N Engl J Med 1983: 309: 809.
11. GJIERTSON DW. Survival trends in long-term first cadaverdonor kidney transplants. In: TERASAKI PI, CECKA JM, eds. Clinical Transplants. Los Angeles: UCLA Tissue Typing Laboratories. 1992: 225.
12. MASSY ZA, GUIJARRO C, WIEDERKEHR MR, MA JZ, KASISKE BL. Chronic renal allograft rejection: immunologic and non-immunologic risk factors. Kidney Int 1996: 49: 518.
13. RUIZ P, KOLBECK PC, SCROGGS MW, SANFILIPPO F. Association between cyclosporine therapy and interstitial fibrosis in renal allograft biopsies. Transplantation 1988: 45: 91.
14. MYERS BD, Ross J, NEWTON L, LUETSCHER J, PERLROTH M. Cyclosporine associated chronic nephropathy. N Engl J Med 1984: 311: 699.
15. REMUZZI G, PERICO N. Cyclosporine-induced dysfunction in experimental animals and humans. Kidney Int 1995: 48: 70.
16. LEWIS RM. Long-term use of cyclosporine A does not adversely impact on clinical outcomes following renal transplantation Kidney Int 1995: 48: 75.
17. BENNETT WM, DEMATTOS A, MEYER MM, ANDOH T, BARRY JM. Chronic cyclosporine nephropathy: The Achilles' heel of immunosupressive therapy. Kidney Int 1996: 50: 1089.
18. LEUNISSEN KM, BOSMAN FT, NIEMAN FH, et al. Amplification of thenephrotoxic effect of cyclosporine by preexistent chronic histological lesions in the kidney. Transplantation 1989: 48: 590.
19. SERÓN D, MORESO F, BOVER J, et al. Early protocol renal allograft biopsies and graft outcome. Kidney Int 1997: 51: 310.